{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"100"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"22"}],"units":"Participants"}],"description":"Success rate of expanding MILs in vitro and obtaining a protocol-specified product.","groups":[{"description":"therapeutic autologous lymphocytes\n\ntherapeutic tumor infiltrating lymphocytes\n\nmelphalan\n\nautologous hematopoietic stem cell transplantation","id":"OG000","title":"MILs in Patients Undergoing an Autologous Peripheral SCT"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"Up to 1 year","title":"Feasibility of MILs Generation as Assessed by Percentage of Participants With Successful MIL Generation","type":"PRIMARY","unitOfMeasure":"percentage of participants"}